Dianthus Therapeutics Statistics

Total Valuation

DNTH has a market cap or net worth of $1.90 billion. The enterprise value is $1.34 billion.

Market Cap	1.90B
Enterprise Value	1.34B

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

DNTH has 42.88 million shares outstanding. The number of shares has increased by 28.44% in one year.

Current Share Class	42.88M
Shares Outstanding	42.88M
Shares Change (YoY)	+28.44%
Shares Change (QoQ)	+5.50%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	91.28%
Float	36.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	616.53
Forward PS	1,839.53
PB Ratio	3.47
P/TBV Ratio	3.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	436.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.35, with a Debt / Equity ratio of 0.00.

Current Ratio	17.35
Quick Ratio	17.09
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.57% and return on invested capital (ROIC) is -19.80%.

Return on Equity (ROE)	-28.57%
Return on Assets (ROA)	-18.82%
Return on Invested Capital (ROIC)	-19.80%
Return on Capital Employed (ROCE)	-25.35%
Revenue Per Employee	$39,462
Profits Per Employee	-$1.62M
Employee Count	78
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.34% in the last 52 weeks. The beta is 1.19, so DNTH's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+79.34%
50-Day Moving Average	37.56
200-Day Moving Average	25.66
Relative Strength Index (RSI)	65.70
Average Volume (20 Days)	779,995

Short Selling Information

The latest short interest is 4.08 million, so 9.52% of the outstanding shares have been sold short.

Short Interest	4.08M
Short Previous Month	4.03M
Short % of Shares Out	9.52%
Short % of Float	11.20%
Short Ratio (days to cover)	7.40

Income Statement

In the last 12 months, DNTH had revenue of $3.08 million and -$126.35 million in losses. Loss per share was -$3.49.

Revenue	3.08M
Gross Profit	3.08M
Operating Income	-140.31M
Pretax Income	-126.35M
Net Income	-126.35M
EBITDA	-140.20M
EBIT	-140.31M
Loss Per Share	-$3.49

Full Income Statement

Balance Sheet

The company has $402.61 million in cash and $1.29 million in debt, giving a net cash position of $554.20 million or $12.93 per share.

Cash & Cash Equivalents	402.61M
Total Debt	1.29M
Net Cash	554.20M
Net Cash Per Share	$12.93
Equity (Book Value)	546.45M
Book Value Per Share	12.75
Working Capital	389.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$109.52 million and capital expenditures -$106,000, giving a free cash flow of -$109.63 million.

Operating Cash Flow	-109.52M
Capital Expenditures	-106,000
Free Cash Flow	-109.63M
FCF Per Share	-$2.56

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-4,558.41%
Pretax Margin	-4,104.78%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DNTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.44%
Shareholder Yield	-28.44%
Earnings Yield	-6.66%
FCF Yield	-5.78%

Analyst Forecast

The average price target for DNTH is $68.00, which is 53.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$68.00
Price Target Difference	53.64%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	108.76%
EPS Growth Forecast (5Y)	-2.22%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DNTH has an Altman Z-Score of 13.49 and a Piotroski F-Score of 1.

Altman Z-Score	13.49
Piotroski F-Score	1